HE4, another biomarker that has been shown to aid CA125 in diagnosing and monitoring ovarian cancer and EC, was reported to predict the existence of lymph node metastasis (16), treatment response (20), and prognosis (21) of EC. The gene discussed is WFDC2; the disease is metastatic malignant neoplasm in the lymph nodes.